Cathy N Lam

Array ( [id] => 6447994 [patent_doc_number] => 20100144873 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'TREATMENT OF MYOCARDITIS USING FTS' [patent_app_type] => utility [patent_app_number] => 12/595636 [patent_app_country] => US [patent_app_date] => 2009-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5066 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20100144873.pdf [firstpage_image] =>[orig_patent_app_number] => 12595636 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6596102 [patent_doc_number] => 20100048587 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'CYSTEINE AND CYSTINE BIOISOSTERES TO TREAT SCHIZOPHRENIA AND REDUCE DRUG CRAVINGS' [patent_app_type] => utility [patent_app_number] => 12/425063 [patent_app_country] => US [patent_app_date] => 2009-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9342 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20100048587.pdf [firstpage_image] =>[orig_patent_app_number] => 12425063 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8664508 [patent_doc_number] => 08377968 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-19 [patent_title] => 'N-piperidinyl acetamide derivatives as calcium channel blockers' [patent_app_type] => utility [patent_app_number] => 12/420793 [patent_app_country] => US [patent_app_date] => 2009-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27199 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12420793 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6039420 [patent_doc_number] => 20110092469 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-21 [patent_title] => 'Quinone derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the treatment of respiratory illness in muscular dystrophy' [patent_app_type] => utility [patent_app_number] => 12/934089 [patent_app_country] => US [patent_app_date] => 2009-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3904 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20110092469.pdf [firstpage_image] =>[orig_patent_app_number] => 12934089 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6306600 [patent_doc_number] => 20100069336 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-18 [patent_title] => 'HIGH PENETRATION PRODRUG COMPOSITIONS OF MUSTARDS AND MUSTARD-RELATED COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/418564 [patent_app_country] => US [patent_app_date] => 2009-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11997 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20100069336.pdf [firstpage_image] =>[orig_patent_app_number] => 12418564 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9588773 [patent_doc_number] => 08778312 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-15 [patent_title] => 'Densensitizing dentifrice exhibiting dental tissue antibacterial agent uptake' [patent_app_type] => utility [patent_app_number] => 13/260799 [patent_app_country] => US [patent_app_date] => 2009-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3546 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13260799 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5496460 [patent_doc_number] => 20090264488 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-22 [patent_title] => 'NOVEL SOLID FORMS OF BENDAMUSTINE HYDROCHLORIDE' [patent_app_type] => utility [patent_app_number] => 12/411929 [patent_app_country] => US [patent_app_date] => 2009-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 12819 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20090264488.pdf [firstpage_image] =>[orig_patent_app_number] => 12411929 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5496393 [patent_doc_number] => 20090264421 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-22 [patent_title] => 'Methods and Compositions for Treating Cancer' [patent_app_type] => utility [patent_app_number] => 12/406444 [patent_app_country] => US [patent_app_date] => 2009-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 23088 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20090264421.pdf [firstpage_image] =>[orig_patent_app_number] => 12406444 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6149941 [patent_doc_number] => 20110021536 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-27 [patent_title] => 'Crystalline Forms and Two Solvated Forms of 4-Amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]quinolin-2(1H)-one Lactic Acid Salts' [patent_app_type] => utility [patent_app_number] => 12/922213 [patent_app_country] => US [patent_app_date] => 2009-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 3994 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20110021536.pdf [firstpage_image] =>[orig_patent_app_number] => 12922213 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5533100 [patent_doc_number] => 20090232888 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-17 [patent_title] => 'SUSTAINED DELIVERY OF ANTIBIOTICS' [patent_app_type] => utility [patent_app_number] => 12/403896 [patent_app_country] => US [patent_app_date] => 2009-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4658 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20090232888.pdf [firstpage_image] =>[orig_patent_app_number] => 12403896 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6136849 [patent_doc_number] => 20110009433 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => 'BICYCLIC PYRROLE COMPOUND' [patent_app_type] => utility [patent_app_number] => 12/921529 [patent_app_country] => US [patent_app_date] => 2009-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5913 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20110009433.pdf [firstpage_image] =>[orig_patent_app_number] => 12921529 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5534170 [patent_doc_number] => 20090233958 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-17 [patent_title] => '(+)-BELOXEPIN AND METHODS FOR ITS SYNTHESIS AND USE' [patent_app_type] => utility [patent_app_number] => 12/388950 [patent_app_country] => US [patent_app_date] => 2009-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 14246 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20090233958.pdf [firstpage_image] =>[orig_patent_app_number] => 12388950 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5404576 [patent_doc_number] => 20090239890 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-24 [patent_title] => 'SPIRO SUBSTITUTED CYCLOPROPANE COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/388984 [patent_app_country] => US [patent_app_date] => 2009-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12713 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20090239890.pdf [firstpage_image] =>[orig_patent_app_number] => 12388984 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5534171 [patent_doc_number] => 20090233959 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-17 [patent_title] => 'BELOXEPIN AND ANALOGS FOR THE TREATMENT OF PAIN' [patent_app_type] => utility [patent_app_number] => 12/388982 [patent_app_country] => US [patent_app_date] => 2009-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 12266 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20090233959.pdf [firstpage_image] =>[orig_patent_app_number] => 12388982 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5534169 [patent_doc_number] => 20090233957 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-17 [patent_title] => '(-)-BELOXEPIN AND METHODS FOR ITS SYNTHESIS AND USE' [patent_app_type] => utility [patent_app_number] => 12/388903 [patent_app_country] => US [patent_app_date] => 2009-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 13821 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20090233957.pdf [firstpage_image] =>[orig_patent_app_number] => 12388903 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9843703 [patent_doc_number] => 08945615 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-02-03 [patent_title] => 'Controlled release budesonide minitablets' [patent_app_type] => utility [patent_app_number] => 12/372333 [patent_app_country] => US [patent_app_date] => 2009-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 3250 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12372333 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9843704 [patent_doc_number] => 08945616 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-02-03 [patent_title] => 'Controlled release budesonide minitablets' [patent_app_type] => utility [patent_app_number] => 12/372359 [patent_app_country] => US [patent_app_date] => 2009-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 2927 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12372359 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8202049 [patent_doc_number] => 08188280 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-29 [patent_title] => '3-substituted sulfonyl piperidine derivative' [patent_app_type] => utility [patent_app_number] => 12/865878 [patent_app_country] => US [patent_app_date] => 2009-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32554 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/188/08188280.pdf [firstpage_image] =>[orig_patent_app_number] => 12865878 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6633168 [patent_doc_number] => 20100311912 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => 'ANTIMICROBIAL SURFACES' [patent_app_type] => utility [patent_app_number] => 12/865045 [patent_app_country] => US [patent_app_date] => 2009-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 15746 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20100311912.pdf [firstpage_image] =>[orig_patent_app_number] => 12865045 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5379338 [patent_doc_number] => 20090191177 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-30 [patent_title] => 'Enantiomerically Pure (-) 2-[1-(7-methyl-2-(morpholin-4-yl)-4-oxo-4H-pyrido[1,2-A]pyrimidin-9-yl)ethylamino]benzoic Acid, Its Use In Medical Therapy, And A Pharmaceutical Composition Comprising It - 026' [patent_app_type] => utility [patent_app_number] => 12/359323 [patent_app_country] => US [patent_app_date] => 2009-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9146 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20090191177.pdf [firstpage_image] =>[orig_patent_app_number] => 12359323 [rel_patent_id] =>[rel_patent_doc_number] =>)